Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Glp-1 receptor agonist use is associated with lower risk of progression from MGUS to SMM or MM in a large real-world cohort

Arooj Abidi, Hashim Mann, Sneha Purvey, Bharadhwaj Kolipakkam, Brian Cassel, Victor Yazbeck

Blood (2025) 146 (Supplement 1): 404.

https://doi.org/10.1182/blood-2025-404

Published: 2025

Journal Articles

Evaluating the clinical outcomes of GLP-1 receptor agonists in untreated indolent non-Hodgkin's lymphomas undergoing active surveillance

Patrick Willard, Esteban Toro Velez, Carolina Velez-Mejia, Maryam Naser, Brian Cassel, Bharadhwaj Kolipakkam, Hashim Mann, Sneha Purvey, Victor Yazbeck

Blood (2025) 146 (Supplement 1): 5385.

https://doi.org/10.1182/blood-2025-5385

Published: 2025

Journal Articles

Impact of obesity on CRS and icans in patients with multiple myeloma receiving bispecific antibodies: A real-world analysis

Maryam Naser, Sneha Purvey, Victor Yazbeck, Bharadhwaj Kolipakkam, Carolina Velez-Mejia, Esteban Toro Velez, Hashim Mann

Blood (2025) 146 (Supplement 1): 7510.

https://doi.org/10.1182/blood-2025-7510

Published: 2025

Journal Articles

Outcomes of CAR-T therapy in HIV-positive multiple myeloma patients: A retrospective database analysis

Esteban Toro Velez, Carolina Velez-Mejia, Patrick Willard, Maryam Naser, Brian Cassel, Bharadhwaj Kolipakkam, Victor Yazbeck, Hashim Mann, Sneha Purvey

Blood (2025) 146 (Supplement 1): 4591.

https://doi.org/10.1182/blood-2025-4591

Published: 2025

Journal Articles

Real-world evaluation of cardiac outcomes after CAR-T in patients with hematologic malignancies

Maryam Naser, Bharadhwaj Kolipakkam, Victor Yazbeck, Patrick Willard, Carolina Velez-Mejia, Esteban Toro Velez, Sneha Purvey

Blood (2025) 146 (Supplement 1): 1892.

https://doi.org/10.1182/blood-2025-1892

Published: 2025

Journal Articles

Suboptimal cancer-screening adherence in CLL/SLL patients

Carolina Velez-Mejia, Esteban Toro Velez, Patrick Willard, Maryam Naser, Brian Cassel, Hashim Mann, Victor Yazbeck, Sneha Purvey, Bharadhwaj Kolipakkam

Blood (2025) 146 (Supplement 1): 4536.

https://doi.org/10.1182/blood-2025-4536

Published: 2025

Journal Articles

Etctn P10500: Phase 1 Study of Tazemetostat Plus Belinostat for the Treatment of Relapsed or Refractory Lymphoma

Jennifer E. Amengual, Aung M. Tun, Ted B. Piorczynski, Yun Kyoung Tiger, Victor Yazbeck, Hua-Jay J Cherng, Seda S. Tolu, Barbara Pro, Diane Durecki, Jan Beumer, Neil Kelleher, Naomi Sender, Sarah Sta Ana, Anxhela Kalia, Beatriz Raposo Corradini, Yu Shyr, Patricia LoRusso, Lorraine Pelosof, Richard Piekarz

Blood (2024) 144 (Supplement 1): 3112.

https://doi.org/10.1182/blood-2024-199650

Published: 2024

Journal Articles

Modeling Marginal Zone Lymphomagenesis

Victor Yazbeck, MD, Ian McConnell, Emily Harris, Joseph Lownik, Ariel Sindel, DO, Roy Sabo, PhD, Alden Chesney, MD, Guanhua Lai, MD PhD, Adolfo Mauro, PhD, Chad Cain, Fadi N. Salloum, Jamal Zweit, PhD, Steven Grant, MD, Jolene Windle, PhD, Steven Grossman, MD

Blood (2020) 136 (Supplement 1): 31.

https://doi.org/10.1182/blood-2020-142768

Published: 2020

Journal Articles

Impact of Histologic Type on Survival in Primary Parotid Lymphomas

Taha Al-Juhaishi, MD, Arushi Khurana, MBBS, Danielle Shafer, DO, Victor Yazbeck, MD

Blood (2019) 134 (Supplement_1): 5882.

https://doi.org/10.1182/blood-2019-130981

Published: 2019

Journal Articles

Primary Ocular Lymphoma: A SEER Database Analysis of Patterns of Involvement and Outcomes

Arushi Khurana, MBBS, Taha Al-Juhaishi, MD, Victor Yazbeck, MD, Danielle Shafer, DO

Blood (2019) 134 (Supplement_1): 4013.

https://doi.org/10.1182/blood-2019-132011

Published: 2019

Journal Articles

Brentuximab Vedotin in Front-Line Therapy of Hodgkin Lymphoma (HL) and CD30-Expressing Peripheral T-Cell Lymphoma (PTCL) in Adults Age 60 and Above

Christopher A. Yasenchak, MD, Rodolfo Bordoni, MD, Victor Yazbeck, MD, Dipti Patel-Donnelly, MD, Timothy Larson, MD, Trevor Newhook, MS, Linda Ho, Matthew Mei, MD

Blood (2019) 134 (Supplement_1): 2852.

https://doi.org/10.1182/blood-2019-122968

Published: 2019

Journal Articles

Venetoclax and Cytarabine in AML Transformed from Myelofibrosis

John McKay, DO, Matthew Gayhart, MD, Taha Al-Juhaishi, MD, Victor Yazbeck, MD, Edward B. Perkins, MD PhD

Blood (2019) 134 (Supplement_1): 5140.

https://doi.org/10.1182/blood-2019-129429

Published: 2019

Journal Articles

Transformation from Indolent Primary Cutaneous Marginal Zone Lymphoma to Aggressive Primary Cutaneous Diffuse Large B-Cell Lymphoma: A Rare Case and Review of the Literature

Emily Harris, Ariel Sindel, DO, Ian McConnell, William Clark, MDMS, Alden Chesney, MD, Victor Yazbeck, MD

Blood (2019) 134 (Supplement_1): 5266.

https://doi.org/10.1182/blood-2019-130921

Published: 2019

Journal Articles

Rive-CLL: Phase 1 Trial of Rituximab, Idelalisib, and Venetoclax in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia

John McKay, DO, Taha Al-Juhaishi, MD, Lai Guanhua, MD PhD, Maciej Kmieciak, PhD, Roy Sabo, PhD, Ariel Sindel, DO, Victor Yazbeck, MD

Blood (2019) 134 (Supplement_1): 5482.

https://doi.org/10.1182/blood-2019-126335

Published: 2019

Journal Articles

Phase 2 Study of Frontline Brentuximab Vedotin Plus Nivolumab in Patients with Hodgkin Lymphoma Aged ≥60 Years

Christopher A. Yasenchak, MD, Rodolfo Bordoni, MD, Victor Yazbeck, MD, Dipti Patel-Donnelly, MD, Thomas Anderson, Timothy Larson, MD, Trevor Newhook, MS, Matthew Mei, MD, Linda Ho, Jonathan W. Friedberg, MD

Blood (2019) 134 (Supplement_1): 237.

https://doi.org/10.1182/blood-2019-124866

Published: 2019

Journal Articles

Tax ubiquitylation and sumoylation control critical cytoplasmic and nuclear steps of NF-κB activation

Rihab Nasr, Estelle Chiari, Marwan El-Sabban, Renaud Mahieux, Youmna Kfoury, Maher Abdulhay, Victor Yazbeck, Olivier Hermine, Hugues de Thé, Claudine Pique, Ali Bazarbachi

Blood (2006) 107 (10): 4021–4029.

https://doi.org/10.1182/blood-2005-09-3572

Published: 2006

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Glp-1 receptor agonist use is associated with lower risk of progression from MGUS to SMM or MM in a large real-world cohort

Evaluating the clinical outcomes of GLP-1 receptor agonists in untreated indolent non-Hodgkin's lymphomas undergoing active surveillance

Impact of obesity on CRS and icans in patients with multiple myeloma receiving bispecific antibodies: A real-world analysis

Outcomes of CAR-T therapy in HIV-positive multiple myeloma patients: A retrospective database analysis

Real-world evaluation of cardiac outcomes after CAR-T in patients with hematologic malignancies

Suboptimal cancer-screening adherence in CLL/SLL patients

Etctn P10500: Phase 1 Study of Tazemetostat Plus Belinostat for the Treatment of Relapsed or Refractory Lymphoma

Modeling Marginal Zone Lymphomagenesis

Impact of Histologic Type on Survival in Primary Parotid Lymphomas

Primary Ocular Lymphoma: A SEER Database Analysis of Patterns of Involvement and Outcomes

Brentuximab Vedotin in Front-Line Therapy of Hodgkin Lymphoma (HL) and CD30-Expressing Peripheral T-Cell Lymphoma (PTCL) in Adults Age 60 and Above

Venetoclax and Cytarabine in AML Transformed from Myelofibrosis

Transformation from Indolent Primary Cutaneous Marginal Zone Lymphoma to Aggressive Primary Cutaneous Diffuse Large B-Cell Lymphoma: A Rare Case and Review of the Literature

Rive-CLL: Phase 1 Trial of Rituximab, Idelalisib, and Venetoclax in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia

Phase 2 Study of Frontline Brentuximab Vedotin Plus Nivolumab in Patients with Hodgkin Lymphoma Aged ≥60 Years

Tax ubiquitylation and sumoylation control critical cytoplasmic and nuclear steps of NF-κB activation

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only